Skip to main content
Clinical Trials/NCT01312259
NCT01312259
Unknown
Phase 4

Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome

Pelvic and Sexual Health Institute1 site in 1 country72 target enrollmentApril 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Painful Bladder Syndrome
Sponsor
Pelvic and Sexual Health Institute
Enrollment
72
Locations
1
Primary Endpoint
Improvement in Urinary symptoms and Bladder pain/discomfort
Last Updated
12 years ago

Overview

Brief Summary

Purpose:

  1. To demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard).
  2. The evaluate the efficacy of the two frequency settings on the other associated conditions that often coexist in patients with IC/PBS, such as female sexual dysfunction (FSD), bowel dysfunction, high tone pelvic floor dysfunction (HTPFD, painful spasm of the pelvic floor muscles), Vulvodynia (pain at the opening of the vagina).

Detailed Description

Purpose: 1. Primary: to demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard). 2. Secondary: The evaluate the efficacy of the two frequency settings on the other associated conditions that often coexist in patients with IC/PBS, such as female sexual dysfunction (FSD), bowel dysfunction, high tone pelvic floor dysfunction (HTPFD, painful spasm of the pelvic floor muscles), Vulvodynia (pain at the opening of the vagina).

Registry
clinicaltrials.gov
Start Date
April 2011
End Date
April 2018
Last Updated
12 years ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Sponsor
Pelvic and Sexual Health Institute
Responsible Party
Principal Investigator
Principal Investigator

Kristene Whitmore, M.D.

Medical Director

Pelvic and Sexual Health Institute

Eligibility Criteria

Inclusion Criteria

  • Female with diagnosis of IC/PBS with implanted IPG Interstim.
  • Scores \> 8 on the Interstitial Cystitis Symptom index questionnaire (ICSI) and \> 8 on the Interstitial Cystitis Problem Index questionnaire (ICPI).
  • Signed Informed Consent.

Exclusion Criteria

  • Progressive neurologic disease or peripheral neuropathy.
  • History of bladder surgery.
  • Subjects implanted with other neuromodulation device.
  • Current or planning pregnancy; Breastfeeding.
  • Subjects who are not deemed able to fill questionnaires
  • Mental illness or mentally unstable patients

Outcomes

Primary Outcomes

Improvement in Urinary symptoms and Bladder pain/discomfort

Time Frame: 1 year

To demonstrate better symptoms control (pain, urinary urgency and frequency) with sacral neuromodulation (SNM) in patients with interstitial cystitis /painful bladder syndrome (IC/PBS) using a stimulation frequency of 40 hertz (experimental) compared to a frequency of 14 hertz (standard).

Secondary Outcomes

  • Improvement in Bowel symptoms and Sexual Function(1 year)

Study Sites (1)

Loading locations...

Similar Trials